Theriva Biologics, Inc. (TOVX) has 7 open-market insider trades by 1 insider since 2022. The most active filer is Shallcross Steven a, CEO and CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Shallcross Steven a | CEO and CFO | — | 7 | $160K | 2023-06-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Shallcross Steven a | CEO and CFO | Buy | $10K | 2023-06-07 |
| Shallcross Steven a | CEO and CFO | Buy | $16K | 2023-06-06 |
| Shallcross Steven a | CEO and CFO | Buy | $26K | 2023-02-10 |
| Shallcross Steven a | CEO and CFO | Buy | $24K | 2023-02-02 |
| Shallcross Steven a | CEO and CFO | Buy | $22K | 2023-01-25 |
| Shallcross Steven a | CEO and CFO | Buy | $19K |
Companies that share insiders with TOVX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-01-20 |
| Shallcross Steven a | CEO and CFO | Buy | $44K | 2022-12-29 |